A case of Carcinoid Crisis Despite High Dose Somatostatin Analogue Therapy Peri-operatively Abstract #2010

Introduction: Carcinoid crisis is a life threatening endocrine emergency. Somatostatin analogues (SSA) are recommended as prophylactic administration before invasive procedures. It remains unclear whether there is an optimal dose of prophylactic somatostatin analogue therapy in the peri-operative period.
Aim(s): A 62 year old female, newly diagnosed with metastatic well-differentiated midgut neuroendocrine tumour and carcinoid syndrome, was admitted for a right hemicolectomy. She had an elevated urinary 5-HIAA of 1327umol/24h (NR 0-50). In light of the biochemical findings, octreotide (500 mcg IV) was administered two hours before surgery, then continuously infused (500 mcg/hr). Intraoperative mobilisation of the bowel caused acute hypercapnia, hypotension and a PEA arrest ensued. Hydrocortisone (400 mg IV) and octreotide (100 mcg IV) were administered after adrenaline (1mg IV). Clinically, the patient was flushed with a wide spread maculopapular rash at the time of the arrest. She responded to additional adrenaline, anti-histamine and octreotide (500mcg/hr). The surgical team decided to continue with the hemicolectomy and ileostomy due to the risk of further cardiovascular instability if a re-laparotomy was to be performed and the clinical concern of imminent bowel obstruction. Post-operatively, the patient was admitted to ITU for 2 days. She has since made a full recovery. She continues on lanreotide (120mg s/c every 21 days).
Materials and methods: NA
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Case reports
Presenting Author: Deborah Pitfield

To read results and conclusion, please login ...

Further abstracts you may be interested in

#137 Extensive ""multitasking"" surgery for advanced neuroendocrine tumors is safe and effective
Introduction: Management of advanced NETs is controversial, related to degree of intervention; the pendulum is swinging towards a more aggressive interventional approach. Our Center's philosophy is to offer a systematic, planned multimodality treatment for patients with advanced NETs.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: MD MICHAIL K Shafir
#796 Somatostatin Analogues for Preventing Carcinoid Crisis
Introduction: Carcinoid crisis is a life-threating syndrome of neuroendocrine tumors (NETs) and is characterized by dramatic blood pressure fluctuation, arrhythmias, and bronchospasm. Somatostatin analogues (SSTA) have been recommended for prophylactic administration before provocative procedures.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Medical treatment - SMS analogues, interferon
Presenting Author: LinJie Guo
Authors: Guo L, Tang C, ...
#1296 The Application of Octreotide in a SINET Patient with Carcinoid Syndrome, Carcinoid Heart Disease and Carcinoid Crisis: A Case Report
Introduction: In Chinese population, small intestinal neuroendocrine tumor (SINET) only accounts for 2.2% of gastroenteropancreatic NET, while carcinoid syndrome, carcinoid heart disease (CHD) and carcinoid crisis are rarer.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Clinical cases/reports
Presenting Author: Luohai Chen
Authors: Chen L, Zhang Y, Chen M, Chen J, ...
#1607 Perioperative Carcinoid Crisis During Surgery- Who Benefits from Octreotide?
Introduction: Carcinoid crisis, as an entity is poorly defined, but can be seen in patients with small bowel NET after open bowel surgery or tumour unrelated procedures as cardiovascular instability (CI)
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Medical treatment - SMS analogues, interferon
Presenting Author: Khalil Elgendy
Authors: Elgendy K, Johnson S, French J, White S, ...
#1685 Intraoperative Carcinoid Syndrome During Small-Bowel NET Surgery: Description, Prevalence and Risk Factors.
Introduction: Few studies on intraoperative carcinoid syndrome (ioCS) are available.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: ...none of the above
Presenting Author: Myrtille Fouché